Skip to main content
Home
  • About
    • About the Navigator
    • Navigator FAQs
  • Guides
    • For Patients and Caregivers
    • For Physicians and Healthcare Providers
    • For Companies and Sponsors
  • Company Directory
    • View Company Directory
    • Submit Company Information
  • Resources
  • Expanded Access eRequest
  • facebook
  • twitter
  • linkedin
  • youtube
Home
  • About
    • About the Navigator
    • Navigator FAQs
  • Guides
    • For Patients and Caregivers
    • For Physicians and Healthcare Providers
    • For Companies and Sponsors
  • Company Directory
    • View Company Directory
    • Submit Company Information
  • Resources
  • Expanded Access eRequest

InflaRx N.V.

By abhat@reaganud… on Tue, 04/14/2020 - 15:43
  • Read more about InflaRx N.V.

Karyopharm Therapeutics

By abhat@reaganud… on Tue, 04/14/2020 - 15:32
  • Read more about Karyopharm Therapeutics

BioCryst Pharmaceuticals, Inc.

By abhat@reaganud… on Tue, 04/14/2020 - 09:57
  • Read more about BioCryst Pharmaceuticals, Inc.

CovidDB: The Covid-19 Inpatient Database

  • Read more about CovidDB: The Covid-19 Inpatient Database

Angiotensin Converting Enzyme Inhibitors in Treatment of Covid 19

  • Read more about Angiotensin Converting Enzyme Inhibitors in Treatment of Covid 19

Management by Hyperbaric Oxygen Therapy of Patients With Hypoxaemic Pneumonia With SARS-CoV-2 (COVID-19)

  • Read more about Management by Hyperbaric Oxygen Therapy of Patients With Hypoxaemic Pneumonia With SARS-CoV-2 (COVID-19)

Laurent Pharmaceuticals

By abhat@reaganud… on Fri, 04/10/2020 - 18:20
  • Read more about Laurent Pharmaceuticals

Pulmotect, Inc.

By abhat@reaganud… on Fri, 04/10/2020 - 18:10
  • Read more about Pulmotect, Inc.

Swedish Orphan Biovitrum AB (SOBI)

By abhat@reaganud… on Fri, 04/10/2020 - 17:58
  • Read more about Swedish Orphan Biovitrum AB (SOBI)

The Safety of Chemotherapy for Patients With Gynecological Malignancy in High-risk Region of COVID-19

  • Read more about The Safety of Chemotherapy for Patients With Gynecological Malignancy in High-risk Region of COVID-19

Pagination

  • First page « First
  • Previous page ‹ Previous
  • …
  • Page 222
  • Page 223
  • Page 224
  • Page 225
  • Current page 226
  • Page 227
  • Page 228
  • Page 229
  • Page 230
  • …
  • Next page Next ›
  • Last page Last »
Subscribe to

Subscribe for updates from the Reagan-Udall Foundation for the FDA

Subscribe
(202) 849 - 2075
1333 New Hampshire Ave, NW
Suite 420
Washington, DC 20036
navigator@reaganudall.org
  • facebook
  • twitter
  • linkedin
  • youtube

© Reagan-Udall Foundation for the FDA
© Reagan-Udall Foundation for the FDA